查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1547523

全球靜脈注射手術設備市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Venous Procedure Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

全球靜脈注射手術器械市場需求預計將從 2023 年的 25.5 億美元達到近 45.2 億美元的市場規模，2024-2032 年研究期間複合年成長率為 6.55%。

靜脈手術裝置是放置在大靜脈的小型軟性管，適用於需要頻繁進入血流的患者。它們允許直接給藥到更突出的靜脈。靜脈手術裝置最常用於施用化療藥物、抗生素、止痛藥等藥物、液體和營養化合物的施用、血液製品的輸注以及用於診斷測試的抽血。

市場動態

預計全球靜脈手術設備市場在預測期內將以驚人的速度成長。全球手術數量不斷增加、生活方式疾病盛行率迅速上升、輸血量不斷增加、尋求緊急治療的患者數量增加以及老年人口不斷增加，這些因素都加速了對靜脈手術設備的需求。此外，以最高的安全性和效率升級產品的推出以及不斷增加的 FDA 批准也有望推動全球秩序。但是，靜脈手術裝置的放置和維護所涉及的高成本以及與血管通路裝置相關的風險阻礙了市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球靜脈手術設備市場的各個細分市場進行了包容性評估。靜脈手術設備產業的成長和趨勢為本研究提供了整體方法。

市場區隔

靜脈手術設備市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按靜脈支架分類（藥物洗脫靜脈支架、非藥物洗脫靜脈支架）

  • 導管（中心靜脈導管、皮下（植入）端口、周邊插入中心靜脈導管 (PICC)）
  • 導絲（標準、高支撐、靈活、慢性完全閉塞）
  • 其他

按產品分類

  • 血管疾病（慢性深部靜脈栓塞、血栓後症候群、適應症May-Thurner症候群、血液透析/動靜脈瘻管、其他）
  • 癌症

按申請

  • 腿
  • 胸部
  • 腹部
  • 手臂

按最終用戶

  • 醫院
  • 門診手術中心
  • 專科診所
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲靜脈手術設備市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。靜脈手術設備市場的主要參與者包括 Medtronic Plc、BD、Cardinal Health、TerumCorporation、Teleflex Incorporated、Boston Scientific Corporation、Optimed Medizinische Instrumente GmbH、Cook、BBraun Melsungen AG、Abbott Laboratories。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：靜脈手術設備 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 靜脈支架市場吸引力分析（藥物洗脫靜脈支架、非藥物洗脫靜脈支架）
    • 按產品分類的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球靜脈手術器械市場分析：按靜脈支架（藥物洗脫靜脈支架、非藥物洗脫靜脈支架）

  • 靜脈支架概述（藥物洗脫靜脈支架、非藥物洗脫靜脈支架）
  • 靜脈支架的歷史和預測數據分析（藥物洗脫靜脈支架、非藥物洗脫靜脈支架）
  • 導管（中心靜脈導管、皮下（植入）端口、周邊插入中心靜脈導管 (PICC)）
  • 導絲（標準、高支撐、靈活、慢性完全閉塞）
  • 其他

第 6 章：全球靜脈注射手術器材市場分析：依產品

  • 概述（按產品）
  • 按產品分類的歷史和預測資料分析
  • 血管疾病（慢性深部靜脈栓塞、血栓後症候群、適應症May-Thurner症候群、血液透析/動靜脈瘻管、其他）
  • 癌症

第 7 章：全球靜脈手術設備市場分析：依應用分類

  • 概述：按應用
  • 歷史和預測數據分析：按應用
  • 腿
  • 胸部
  • 腹部
  • 手臂

第 8 章：全球靜脈手術設備市場分析：依最終使用者分類

  • 最終用戶概述
  • 最終用戶的歷史和預測數據分析
  • 醫院
  • 門診手術中心
  • 專科診所
  • 其他

第 9 章：全球靜脈手術設備市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：靜脈手術器械公司的競爭格局

  • 靜脈注射手術器械市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Medtronic Plc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • BD
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Cardinal Health
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • TerumCorporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Teleflex Incorporated
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Boston Scientific Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Optimed Medizinische Instrumente GmbH
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Cook
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • BBraun Melsungen AG
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Abbott Laboratories
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR11215078

The global demand for Venous Procedure Devices Market is presumed to reach the market size of nearly USD 4.52 Billion by 2032 from USD 2.55 Billion in 2023 with a CAGR of 6.55% under the study period 2024-2032.

Venous procedure devices are small flexible tubes placed in large veins for patients who require frequent access to the bloodstream. They allow administration directly into more prominent veins. Venous procedure devices are most often used to administer medications such as chemotherapy drugs, antibiotics, pain medications, among others, administration of fluids and nutritional compounds, transfusion of blood products, and blood draws for diagnostic testing.

MARKET DYNAMICS

The global venous procedure devices market is projected to grow at a remarkable rate during the forecast period. The rising numbers of surgeries performed globally, rapidly increasing prevalence of lifestyle diseases, growing blood transfusion, rise in the number of patients seeking acute treatment, and escalating elderly population are factors accelerating demand for venous procedure devices. In addition, escalation product launches with utmost safety and efficiency and growing FDA approvals are also expected to drive the global order. But, high costs involved in the placement and maintenance of venous procedure devices and risks associated with vascular access devices obstruct market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Venous Procedure Devices. The growth and trends of Venous Procedure Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Venous Procedure Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Venous Stents (Drug Eluting Venous Stent, Non-drug Eluting Venous Stent)

  • Catheters (Central Venous Catheter, Subcutaneous (Implanted) Port, Peripherally Inserted Central Catheter (PICC))
  • Guidewires (Standard, High Support, Flexible, Chronic Total Occlusion)
  • Others

By Product

  • Vascular Disease (Chronic Deep Vein Thrombosis, Post-thrombotic Syndrome, Indication May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae, Others)
  • Cancer

By Application

  • Leg
  • Chest
  • Abdomen
  • Arm

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Venous Procedure Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Venous Procedure Devices market include Medtronic Plc, BD, Cardinal Health, TerumCorporation, Teleflex Incorporated, Boston Scientific Corporation, Optimed Medizinische Instrumente GmbH, Cook, BBraun Melsungen AG, Abbott Laboratories. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. VENOUS PROCEDURE DEVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Venous Stents (Drug Eluting Venous Stent, Non-drug Eluting Venous Stent)
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL VENOUS PROCEDURE DEVICES MARKET ANALYSIS BY VENOUS STENTS (DRUG ELUTING VENOUS STENT, NON-DRUG ELUTING VENOUS STENT)

  • 5.1. Overview By Venous Stents (Drug Eluting Venous Stent, Non-drug Eluting Venous Stent)
  • 5.2. Historical and Forecast Data Analysis By Venous Stents (Drug Eluting Venous Stent, Non-drug Eluting Venous Stent)
  • 5.3. Catheters (Central Venous Catheter, Subcutaneous (Implanted) Port, Peripherally Inserted Central Catheter (PICC)) Historic and Forecast Sales By Regions
  • 5.4. Guidewires (Standard, High Support, Flexible, Chronic Total Occlusion) Historic and Forecast Sales By Regions
  • 5.5. Others Historic and Forecast Sales By Regions

6. GLOBAL VENOUS PROCEDURE DEVICES MARKET ANALYSIS BY PRODUCT

  • 6.1. Overview By Product
  • 6.2. Historical and Forecast Data Analysis By Product
  • 6.3. Vascular Disease (Chronic Deep Vein Thrombosis, Post-thrombotic Syndrome, Indication May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae, Others) Historic and Forecast Sales By Regions
  • 6.4. Cancer Historic and Forecast Sales By Regions

7. GLOBAL VENOUS PROCEDURE DEVICES MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Leg Historic and Forecast Sales By Regions
  • 7.4. Chest Historic and Forecast Sales By Regions
  • 7.5. Abdomen Historic and Forecast Sales By Regions
  • 7.6. Arm Historic and Forecast Sales By Regions

8. GLOBAL VENOUS PROCEDURE DEVICES MARKET ANALYSIS BY END USER

  • 8.1. Overview By End User
  • 8.2. Historical and Forecast Data Analysis By End User
  • 8.3. Hospitals Historic and Forecast Sales By Regions
  • 8.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 8.5. Specialty Clinics Historic and Forecast Sales By Regions
  • 8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL VENOUS PROCEDURE DEVICES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE VENOUS PROCEDURE DEVICES COMPANIES

  • 10.1. Venous Procedure Devices Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF VENOUS PROCEDURE DEVICES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Medtronic Plc
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. BD
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Cardinal Health
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. TerumCorporation
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Teleflex Incorporated
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Boston Scientific Corporation
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Optimed Medizinische Instrumente GmbH
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Cook
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. BBraun Melsungen AG
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Abbott Laboratories
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Venous Stents (Drug Eluting Venous Stent, Non-drug Eluting Venous Stent) (USD MN)
  • Catheters (Central Venous Catheter, Subcutaneous (Implanted) Port, Peripherally Inserted Central Catheter (PICC)) Market Sales By Geography (USD MN)
  • Guidewires (Standard, High Support, Flexible, Chronic Total Occlusion) Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Product (USD MN)
  • Vascular Disease (Chronic Deep Vein Thrombosis, Post-thrombotic Syndrome, Indication May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae, Others) Market Sales By Geography (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Leg Market Sales By Geography (USD MN)
  • Chest Market Sales By Geography (USD MN)
  • Abdomen Market Sales By Geography (USD MN)
  • Arm Market Sales By Geography (USD MN)
  • Analysis By End User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Specialty Clinics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Venous Procedure Devices Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Venous Procedure Devices Report
  • Market Research Process
  • Market Research Methodology
  • Global Venous Procedure Devices Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Venous Stents (Drug Eluting Venous Stent, Non-drug Eluting Venous Stent)
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Venous Stents (Drug Eluting Venous Stent, Non-drug Eluting Venous Stent) (USD MN)
  • Catheters (Central Venous Catheter, Subcutaneous (Implanted) Port, Peripherally Inserted Central Catheter (PICC)) Market Sales By Geography (USD MN)
  • Guidewires (Standard, High Support, Flexible, Chronic Total Occlusion) Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Product (USD MN)
  • Vascular Disease (Chronic Deep Vein Thrombosis, Post-thrombotic Syndrome, Indication May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae, Others) Market Sales By Geography (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Leg Market Sales By Geography (USD MN)
  • Chest Market Sales By Geography (USD MN)
  • Abdomen Market Sales By Geography (USD MN)
  • Arm Market Sales By Geography (USD MN)
  • Global Market Analysis By End User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Specialty Clinics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.